Michael Page?s salary survey: know your worth

Allergan has a strong R&D pipeline of programs that it believes will lead to differentiated, unique products that meet significant unmet patient and customer needs. Allergan's major investments in leading new technologies have enabled the Company to pioneer important new potential approaches to treating serious diseases:

  • Receptor selective retinoids for cancer, metabolic and dermatological disease
  • Second generation alpha agonists for glaucoma
  • Foldable intraocular lenses for cataracts
  • Neurotoxins for a variety of neuromuscular diseases
  • Innovative approaches to treating severe dry eye
  • Novel agents for other ophthalmic needs such as retinal neuroprotection

Job Search

job type

time period

Keyword type

Submit your CV

Client Navigation